Pharmacists in Greeneville, Tennessee
64 Pharmacists found in Greeneville
Mr. Rick Eugene Ealy, D.PH.
Pharmacist
1420 Tusculum Blvd., Laughlin Memorial Hospital Pharmacy, Greeneville, TN 37745
423-787-5065 423-787-5067
Dr. Robert David Mcneese, PHARM.D.
Pharmacist
1004 Snapps Ferry Rd, Greeneville, TN 37745
423-638-7552 423-638-2552
Dr. Robert Michael Monahan, PHARMD
Pharmacist
1004 Snapps Ferry Rd, Greeneville, TN 37745
423-638-7552 423-638-2552
Robert Earnest Keasling Iii, PHARMD
Pharmacist
104 Asheville Hwy, Greeneville, TN 37743
423-636-8335
Ms. Shawn Lee Hope, D.PH.
Pharmacist
1420 Tusculum Blvd, Greeneville, TN 37745
423-787-5065 423-787-5067
Shelly Joy Lewis, R.PH.
Pharmacist
1402 Tusculum Blvd, Greeneville, TN 37745
423-588-5099 423-588-5935
Dr. Stephanie Nicole Rice, PHARM.D.
Pharmacist
3755 E Andrew Johnson Hwy, Greeneville, TN 37745
423-639-7139 423-639-0034
Dr. Thomas Spurgeon, PHARMD
Pharmacist
1650 E Andrew Johnson Hwy, Greeneville, TN 37745
423-638-4889
Dr. Wade T Tugman, RPH,PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
438 E Vann Rd, Greeneville, TN 37743
423-278-1800
Miss Whitney Lawson, PHARMD
Pharmacist
906 Tusculum Blvd, Greeneville, TN 37745
423-638-7101 423-638-9105
Dr. William Giddings, PHARM D
Pharmacist
511 Asheville Hwy, Greeneville, TN 37743
423-639-5155 423-639-2476
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.